Psychometric evaluation of the NFOSI-18 disease related symptoms – Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004
Authors:
- Xiaodan TangXTXiaodan Tang
- Helen HuangHHHelen Huang
- John D. PeipertJPJohn D. Peipert
- Anne ZolaAZAnne Zola
- Joseph BuscemaJBJoseph Buscema
- Kathleen YangKYKathleen Yang
- William TewWTWilliam Tew
- Roisin E. O'CEarbhaillRORoisin E. O'CEarbhaill
- Carolyn MullerCMCarolyn Muller
- Michael J. GoodheartMGMichael J. Goodheart
- Richard G. MooreRMRichard G. Moore
- Rebecca LiuRLRebecca Liu
- 8 June 2026
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 210, 174-182
Abstract
No abstract availableKeywords
Funding Information
- University of Kentucky
- Duke University
- University of North Carolina
- National Institutes of Health
- Cedars-Sinai Medical Center
- Medical College of Wisconsin
- University of Minnesota
- Opportunity Network
- Abramson Cancer Center
- Cancer Center, University of Colorado
- Wake Forest University
- NorthShore University HealthSystem
- University of Kansas
- University of California, San Francisco
- Medical Center, University of Pittsburgh
- Moores Cancer Center, UC San Diego Health
- University of Cincinnati
- Wayne State University
- Thomas Jefferson University
- Masonic Cancer Center, University of Minnesota
- Markey Cancer Center, University of Kentucky
- University of Pennsylvania
- Cook County
- University of Texas Southwestern Medical Center
- Comprehensive Cancer Center, University of Alabama at Birmingham
- Sidney Kimmel Comprehensive Cancer Center
- University of Michigan
- Dartmouth Cancer Center
- University of Alabama
- Hartford Hospital
- Mayo Clinic
- University of South Alabama
- National Cancer Institute (GY004)
- National Cancer Institute (U10CA180822)
- National Cancer Institute (UG1CA189867)
- National Cancer Institute (U10CA180868)
- University of Oklahoma Health Sciences Center
- University of Delaware
This publication has 22 references indexed in Scilit:
- Likely change indexes improve estimates of individual change on patient-reported outcomesQuality of Life Research, 2022
- In our patient‐centered era, it is time we gave patient‐reported outcomes their dueCancer, 2020
- Patient-reported outcomes in randomised controlled trials of gynaecological cancers: Investigating methodological quality and impact on clinical decision-makingEuropean Journal of Cancer, 2014
- A new index of priority symptoms in advanced ovarian cancerGynecologic Oncology, 2011
- Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-GJournal of Clinical Epidemiology, 2010
- Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomesJournal of Clinical Epidemiology, 2008
- A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scaleJournal of Clinical Epidemiology, 2004
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Responsiveness and validity in health status measurement: A clarificationJournal of Clinical Epidemiology, 1989
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951